Sign in to view content

Learnings From the Lampalizumab Chroma and Spectri Phase 3 Trials: Effect of Baseline Characteristics on Geographic Atrophy Progression

Carl D. Regillo, MD

Video
Published 2018

Related

Structural Outcomes and Imaging Observations Following Scleral Window to Treat Exudative Detachment in Uveal Effusion Syndrome
Prithvi Mruthyunjaya, MD, MHS
Annual Meeting Talks
2018
APX3330, an Oral Drug in Trial for DR and DME, Demonstrated a Favorable Safety and Tolerability Profile in Multiple Phase 1 and 2 Studies
Michael J Allingham, MD, PhD
Annual Meeting Talks
2021
Episode 1: Review of the Clarity Study with Dr. Amin Kherani
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017

Category: Age-Related Macular Degeneration

See more